PTC is committed to bringing hope to patients with rare and genetic diseases.
Our scientists are finding new ways to regulate biology to control disease.
We are developing new treatments for Duchenne Muscular Dystrophy, Cystic Fibrosis and other diseases.
About PTC Clinical Trials Careers at PTC PTC STRIVE Awards Program
PTC Therapeutics' Ceo Stuart W. Peltz, Ph.d. Finalist For The 2015 Njbiz Innovation Hero Award
PTC Therapeutics Appoints Glenn D. Steele Jr., M.d., Ph.d. To Board Of Directors
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
View all latest news